Stock Research: Personalis

Independent, rules-based stock research to judge this stock's true performance: Cut through market noise and find high-growth or high-value gems from 8,000+ stocks worldwide.

Personalis

NMQ:PSNL US71535D1063
88
  • Value
    83
  • Growth
    65
  • Safety
    Safety
    68
  • Combined
    88
  • Sentiment
    61
  • 360° View
    360° View
    88
Unlock
What factors are driving this 360° View?
Subscribe to View
Company Description

Personalis, Inc. develops, markets, and sells advanced cancer genomic tests and analytics to support personalized cancer vaccines and immunotherapies. Its main businesses include genomic sequencing and analytics, with products like NeXT Personal, ImmunoID NeXT, NeXT Personal Dx, NeXT Dx, whole exome sequencing (WES), and whole genome sequencing (WGS). The company's tests and analytics are used by pharmaceutical companies for translational research, biomarker discovery, and personalized cancer therapies. In the last fiscal year, the company had a market cap of $563 million, profits of $27 million, revenue of $85 million, and 229 employees.

more

ANALYSIS: With an Obermatt 360° View of 88 (better than 88% compared with alternatives) for 2026, overall professional sentiment and financial characteristics for the stock Personalis are very positive. The 360° View is based on consolidating four consolidated indicators, with all four indicators above average for Personalis. The consolidated Value Rank has an attractive rank of 83, which means that the share price of Personalis is on the lower side compared with the typical size in indicators such as revenues, profits, and invested capital. This means the stock price is lower than for 83% of alternative stocks in the same industry. The consolidated Growth Rank has a good rank of 65, which means that the company experiences above-average growth momentum when looking at financial metrics such as revenue, profit, and invested capital growth as well as stock returns. The company is also safely financed with a Safety rank of 68. Finally, professional market sentiment is above average compared with other stock investment alternatives with a Sentiment Rank of 61. ...read more

more
Index
NASDAQ
Similar Add to Watchlist Similar See Similar Stocks
The higher the 360° View, the better the stock performed against its peers, considering all metrics. The 360° View represents an average of the other 5 ranks and is then scaled to a rank from 1 to 100. The shaded values are illustrative only.
Last update: 26-Mar-2026.

Make Sense of the Ranks

The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.

Detailed and Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.

Unlock Ranks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Value
83 28 85 71
Growth
65 55 39 7
Safety
Safety
68 26 79 90
Sentiment
61 70 64 29
360° View
360° View
88 41 91 51
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Analyst Opinions
28 71 67 64
Opinions Change
50 36 50 50
Pro Holdings
n/a 51 41 19
Market Pulse
81 75 51 38
Sentiment
61 70 64 29
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Value
83 28 85 71
Growth
65 55 39 7
Safety Safety
68 26 79 90
Combined
88 14 82 56
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Price vs. Sales (P/S)
64 35 91 38
Price vs. Earnings (P/E)
71 88 88 30
Price vs. Book (P/B)
27 43 88 94
Dividend Yield
1 1 1 1
Value
83 28 85 71
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Revenue Growth
64 14 14 8
Profit Growth
47 73 56 26
Capital Growth
41 28 71 87
Stock Returns
72 100 35 7
Growth
65 55 39 7
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Leverage
38 62 68 100
Refinancing
97 47 89 99
Liquidity
34 1 7 1
Safety Safety
68 26 79 90

Similar Stocks

Discover high‑ranked alternatives to Personalis and broaden your portfolio horizons.

Omnicom

NYQ:OMC
Country: USA
Industry: Advertising
Size: X-Large
Full Stock Analysis

ResMed

NYQ:RMD
Country: USA
Industry: Health Care Equipment
Size: X-Large
Full Stock Analysis

Aramark

NYQ:ARMK
Country: USA
Industry: Restaurants
Size: X-Large
Full Stock Analysis

FedEx

NYQ:FDX
Country: USA
Industry: Air Freight & Logistics
Size: XX-Large
Full Stock Analysis

Frequently Asked
Questions

This is an all-around strong stock. It shows good value, high growth, safe financing, and positive professional sentiment. It is ideal for most buy-and-hold investors who value a good all-around stock.

Obermatt provides unbiased stock analysis as a completely independent third party. We have no conflicts of interest with individual stock titles. Our data-driven analysis is based on algorithms honed over twelve years, giving you analysis that is free from personal bias and conflicts of interest.

The 360° View Rank indicates a company's overall performance across all major financial and non-financial metrics tracked by Obermatt. A 360° View Rank of 75 means the company is more well-rounded than 75% of similar companies. A high score indicates that the company is strong across the board; it is attractively priced, growing sustainably, financially stable, and well-regarded by the market. Learn more.

Become an Obermatt subscriber and see all of the similar stocks here.

The Obermatt Advantage

Ready to Elevate Your Investing?
Get Started Today

Choose the Obermatt subscription that best fits your needs.


30-day money back guarantee. Your subscription will renew until you cancel it, which you can do at any time.

What Our Customers Say

See how Obermatt improved their investing: